The global anti-microbial/anti-fungal tests market is poised for significant growth, expected to reach USD 2.5 billion by the end of 2022. With a projected CAGR of 5.7% over the forecast period, the market is anticipated to surpass USD 4.5 billion by 2032. The increasing prevalence of microbial and fungal infections, along with rising awareness of …